Nothing Special   »   [go: up one dir, main page]

Haukenes et al., 1975 - Google Patents

False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure

Haukenes et al., 1975

Document ID
8197771409617237181
Author
Haukenes G
Blom H
Publication year
Publication venue
Medical microbiology and immunology

External Links

Snippet

A floatation centrifugation procedure is described by which antibodies and non-specific rubella virus haemagglutination inhibitors can be completely separated. Using this method it was shown that false positive reactions occur with the conventional pretreatments of sera for …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Haukenes et al. False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure
Laver The structure of influenza viruses: 3. Disruption of the virus particle and separation of neuraminidase activity
Hierholzer et al. Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation
Mürer et al. Isolation and studies of the granules of the amebocytes of Limulus polyphemus, the horseshoe crab
Ada et al. Electrophoretic studies of virus-red cell interaction: mobility gradient of cells treated with viruses of the influenza group and the receptor-destroying enzyme of V. cholerae
Alderman et al. Isolation and characterization of an age-related antigen present on senescent human red blood cells
US4702909A (en) Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
Triglia et al. Titers of nine complement components, conglutinin and C3b-inactivator in adult and fetal bovine sera
DK165958B (en) Method for the isolation of proteins of HTLV-III, serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions and detection of HTLV-III infections by immunoassays, and a test system for use in the method
EP0105465A2 (en) Process for producing adult T cell leukemia associated antigen
FI63493C (en) PAIDISANDE AV HEPATITIS B YTANTIGEN GENOM LATEX AGGLUTINATION
Pinder et al. Association state of human red blood cell band 3 and its interaction with ankyrin
Bartholomew et al. Differences in activation of human and guinea pig complement by retroviruses
US4695537A (en) Particles sensitized with detergent-treated antigen for agglutination immunoassay
EP0101166B1 (en) Method of measuring infectious disease antibodies
US4808518A (en) Recovery of cytomegalovirus antigen and use thereof in an assay
Meissner [22] Isolation of sarcoplasmic reticulum from skeletal muscle
US4797475A (en) Method and composition for isolating white cell elements
US4988629A (en) Lactoferrin-containing incubation medium for solid-phase immunometric methods and its use
CN111537326B (en) Method for preparing freeze-dried blood platelet and application thereof
KR890002632B1 (en) Process for preparing reagent to assaying atl virus antibody
Aarli Localization and Properties of an Acid‐Solubl'e Muscle Antigen Reacting with Antibodies in Myasthenia Gravis Sera
NO157358B (en) ANTIBODY REAGENT AND PROCEDURE FOR QUICK DETERMINATION OF PRESENCE OR REQUIREMENTS ON RED ANTIGEN BLOOD CELLS.
Nakamura et al. Membrane fluidity change in erythrocytes induced by complement system
EP0151599B1 (en) Enucleated polymorphonuclear leukocytes, their preparation and use